Fatty acid binding protein 4 as a biomarker for improvement of type 2 diabetes

被引:0
|
作者
Mehra, R. [1 ]
Stentz, F. [1 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
140
引用
收藏
页码:S75 / S75
页数:1
相关论文
共 50 条
  • [41] High Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes
    Li, Jer-Chuan
    Wu, Du-An
    Hou, Jia-Sian
    Subeq, Yi-Maun
    Chen, Hsin-Dean
    Hsu, Bang-Gee
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [42] Adipocyte fatty acid-binding protein in patients with type 2 diabetes: Its relationship to vascular damage
    Kubickova, V.
    Karasek, D.
    Spurna, J.
    Krystynik, O.
    Petrova, P.
    Cibickova, L.
    CLINICA CHIMICA ACTA, 2019, 493 : S309 - S309
  • [43] Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes
    Gruber, Noah
    Rathaus, Moran
    Ron, Idit
    Livne, Rinat
    Sheinvald, Sharon
    Barhod, Ehud
    Hemi, Rina
    Tirosh, Amit
    Pinhas-Hamiel, Orit
    Tirosh, Amir
    DIABETOLOGIA, 2022, 65 (02) : 366 - 374
  • [44] Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes
    Noah Gruber
    Moran Rathaus
    Idit Ron
    Rinat Livne
    Sharon Sheinvald
    Ehud Barhod
    Rina Hemi
    Amit Tirosh
    Orit Pinhas-Hamiel
    Amir Tirosh
    Diabetologia, 2022, 65 : 366 - 374
  • [45] Associations between Fatty Acid-Binding Protein 4-A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus
    Trojnar, Marcin
    Patro-Malysza, Jolanta
    Kimber-Trojnar, Zaneta
    Leszczynska-Gorzelak, Bozena
    Mosiewicz, Jerzy
    CELLS, 2019, 8 (03)
  • [46] Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease
    Atsuko Kamijo
    Takeshi Sugaya
    Akihisa Hikawa
    Masaya Yamanouchi
    Yasunobu Hirata
    Toshihiko Ishimitsu
    Atsushi Numabe
    Masao Takagi
    Hiroshi Hayakawa
    Fumiko Tabei
    Tokuichiro Sugimoto
    Naofumi Mise
    Masao Omata
    Kenjiro Kimura
    Molecular and Cellular Biochemistry, 2006, 284 : 175 - 182
  • [47] Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease
    Kamijo, Atsuko
    Sugaya, Takeshi
    Hikawa, Akihisa
    Yamanouchi, Masaya
    Hirata, Yasunobu
    Ishimitsu, Toshihiko
    Numabe, Atsushi
    Takagi, Masao
    Hayakawa, Hiroshi
    Tabei, Fumiko
    Sugimoto, Tokuichiro
    Mise, Naofumi
    Omata, Masao
    Kimura, Kenjiro
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 284 (1-2) : 175 - 182
  • [48] Serum Fatty Acid Binding Protein 4 (FABP4) Predicts Pre-eclampsia in Women With Type 1 Diabetes
    Wotherspoon, Amy C.
    Young, Ian S.
    McCance, David R.
    Patterson, Chris C.
    Maresh, Michael J. A.
    Pearson, Donald W. M.
    Walker, James D.
    Holmes, Valerie A.
    DIABETES CARE, 2016, 39 (10) : 1827 - 1829
  • [49] Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Wu, Haiya
    Jia, Weiping
    Bao, Yuqian
    Lu, Junxi
    Zhu, Jiehua
    Wang, Ren
    Chen, Yaqing
    Xiang, Kunsan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 185 - 190
  • [50] Fatty Acid Binding Protein 4, FABP4, Causes Impaired Wound Healing in Diabetes
    Boniakowski, Anna
    Kimball, Andrew
    Davis, Frank
    Joshi, Amrita
    Schaller, Matt
    denDekker, Aaron
    Kunkel, Steve
    Gallagher, Katherine
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38